Scholarlink

<p>Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (<a href="http://www.EATRIS.eu">www.EATRIS.eu</a>), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activities of member facilities of EATRIS towards quality assessment of pre-clinical sample processing, clinical omics data generation, multi-omics data integration, and dissemination of the resources in a Multi-Omics Toolbox, which is the principal deliverable of the EATRIS-Plus project for the consolidation of EATRIS towards translational medicine.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Multi-omics Quality Assessment in Personalized Medicine Through European Infrastructure for Translational Medicine (EATRIS): An Overview

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年4月1日

查看全文
  • Patricia Alonso-Andrés,
  • Davide Baldazzi,
  • Qiaochu Chen,
  • Elisa Conde Moreno,
  • Lorena Crespo-Toro,
  • Kati Donner,
  • Petr Džubák,
  • Sara Ekberg,
  • Maria Laura García Bermejo,
  • Daniela Gasparotto,
  • Bishwa Ghimire,
  • Jolein Gloerich,
  • Alain van Gool,
  • Janine Habier,
  • Marián Hajdúch,
  • Rashi Halder,
  • Sari Hannula,
  • Peter-Bram ´t Hoen,
  • Hanna Lindgren,
  • Yaqing Liu,
  • Roberta Maestro,
  • Tom Martin,
  • Pirkko Mattila,
  • Lukáš Najdekr,
  • Kenneth Nazir,
  • Anna Niehues,
  • Anni I. Nieminen,
  • Jessica Nordlund,
  • Emanuela Oldoni,
  • Elin Övernäs,
  • Aino Palva,
  • Maija Puhka,
  • Ileana Quintero,
  • Miren Edurne Ramos-Muñoz,
  • Esperanza Macarena Rodríguez-Serrano,
  • Sabrina Saracino,
  • Andreas Scherer,
  • Leming Shi,
  • Jarmila Stanková,
  • Tanushree Tunstall,
  • Beatrice Valenti,
  • Janneke Weiss,
  • Bhagwan Yadav,
  • Yuanting Zheng,
  • Patricia Žižkovičová

摘要

Molecular characterization of a biological sample, e.g., with omics approaches, is fundamental for the development and implementation of personalized and precision medicine approaches. In this context, quality assessment is one of the most critical aspects. Accurate performance and interpretation of omics techniques is based on consensus, harmonization, and standardization of protocols, procedures, data analysis and reference values and materials. EATRIS, the European Infrastructure for Translational Medicine (www.EATRIS.eu), brings together resources and services to support researchers in developing their biomedical discoveries into novel translational tools and interventions for better health outcomes. Here we describe the efforts within the Horizon 2020 EATRIS-Plus project and activities of member facilities of EATRIS towards quality assessment of pre-clinical sample processing, clinical omics data generation, multi-omics data integration, and dissemination of the resources in a Multi-Omics Toolbox, which is the principal deliverable of the EATRIS-Plus project for the consolidation of EATRIS towards translational medicine.